Efficacy and safety of emapalumab in macrophage activation syndrome

OBJECTIVES: Macrophage activation syndrome (MAS) is a severe, life-threatening complication of systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD). The objective of this study was to confirm the adequacy of an emapalumab dosing regimen in relation to interferon-γ (IF...

Descripción completa

Detalles Bibliográficos
Autores principales: De Benedetti, Fabrizio, Grom, Alexei A, Brogan, Paul A, Bracaglia, Claudia, Pardeo, Manuela, Marucci, Giulia, Eleftheriou, Despina, Papadopoulou, Charalampia, Schulert, Grant S, Quartier, Pierre, Antón, Jordi, Laveille, Christian, Frederiksen, Rikke, Asnaghi, Veronica, Ballabio, Maria, Jacqmin, Philippe, de Min, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314091/
https://www.ncbi.nlm.nih.gov/pubmed/37001971
http://dx.doi.org/10.1136/ard-2022-223739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314091/
https://www.ncbi.nlm.nih.gov/pubmed/37001971
http://dx.doi.org/10.1136/ard-2022-223739

Ejemplares similares